Aldeyra Therapeutics, Inc.
ALDX· Nasdaq
ALDXAldeyra Therapeutics, Inc.
Filed Mar 11, 2021 · 10-K · 70 days after period end · 0001564590-21-012501
derived · Computed from the longer spans the company filed.
| Metric | Q4 2020dderived from reported figures | Q4 2019dderived from reported figures | Q4 2018dderived from reported figures | Q4 2017dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$11.29M | -$13.16M | -$10.63M | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Aldeyra Therapeutics, Inc. · CIK 1341235 · Engraved from SEC EDGAR
ended Dec 31, 2020 · filed Mar 11, 2021 · 70 d after period end
